Vestal Point Capital »

Arcellx shares owned by Vestal Point Capital

Quarter-by-quarter ownership of Arcellx (ACLX) shares owned by Vestal Point Capital from 13F filings

Historical chart of Vestal Point Capital investment in Arcellx

Tip: Access up to 7 years of quarterly data

All positions including Arcellx held by Vestal Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcellx by Vestal Point Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $37M 675k 55.19

More positions owned by Vestal Point Capital

Jazz Pharmaceuticals Shs Usd (JAZZ)
Cytokinetics Com New (CYTK)
Ascendis Pharma A/S Sponsored Adr (ASND)
Ultragenyx Pharmaceutical (RARE)
Globus Medical Cl A (GMED)
Insmed Com Par $.01 (INSM)
BeiGene Sponsored Adr (BGNE)
Soleno Therapeutics (SLNO)
EXACT Sciences Corporation (EXAS)
Arcellx Common Stock (ACLX)
Immatics NV SHS (IMTX)
Janux Therapeutics (JANX)
Astria Therapeutics (ATXS)
Kalvista Pharmaceuticals (KALV)
Savara (SVRA)

View all positions for Vestal Point Capital

Top funds holding Arcellx

FMR
Perceptive Advisors
Paradigm Biocapital Advisors
NEA Management Company
BlackRock
Sr One Capital Management
Vanguard Group
Henderson Group
State Street Corporation
T. Rowe Price Associates
RA Capital Management
Cormorant Asset Management
Suvretta Capital Management
T. Rowe Price Investment Management
Geode Capital Management

View all funds holding Arcellx